Merged House Health Bill Seeks More Part D Drug Savings, Sets Broad Medicaid Expansion
This article was originally published in The Pink Sheet Daily
Executive Summary
Many of the bill's provisions specifically related to the biopharmaceutical industry are relatively unchanged from earlier versions that emerged from three House committees.